Any stock, in context
NEULANDLAB · Healthcare
Neuland Laboratories Ltd.
Observation · 15 Oct 2026
How these are readNeuland Laboratories closed at ₹19,955 on 15 Oct 2026, 16.4% above its 200-day average and 10.9% below its 50-day average: above the long line, below the short one. It sits 16.8% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 8.5%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +16.4%
- the long line
- vs 50-day
- −10.9%
- the short line
- From 52w high
- −16.8%
- ₹11,500₹24,225
- 3 months
- +8.4%
- sector median −2.7% · 42 of 146
Nifty Smallcap 250 · Healthcare · EQ series · median traded value ₹91 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −1.21%
- 1W
- –
- 1M
- −11.68%
- 3M
- +8.45%
- YTD
- –
- 1Y
- +24.19%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.